Announcements Trials

Browse Landscape

Phase

Phase 2 2 Phase 3 1

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Pathologic Complete Response 1

Interventions

pembrolizumab 222 Carboplatin 215 Cisplatin 203 Paclitaxel 181 Gemcitabine 148 Docetaxel 126 Capecitabine 114 Cyclophosphamide 102 Pemetrexed 100 Dexamethasone 100 Specimen Handling 99 Magnetic Resonance Spectroscopy 97 Oxaliplatin 96 Radiotherapy 94 Doxorubicin 91 Fluorouracil 88 Bevacizumab 84 Leucovorin 73 Nivolumab 72 Rituximab 71 Vincristine 68 durvalumab 65 Lenalidomide 64 Radiation 62 atezolizumab 61 Irinotecan 61 Etoposide 60 130-nm albumin-bound paclitaxel 58 Prednisone 55 Letrozole 55

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × FOLFOXIRI protocol × 1 year × Clear all

NCT07472868 2026-03-16

MEND-IT II

Catharina Ziekenhuis Eindhoven

Phase 3 Not yet recruiting

Pathologic Complete Response

Data powered by HemOnc (CC BY 4.0) Colophon ⚡